The Long-Term Use of Methotrexate Monotherapy as a Steroid-Sparing Agent for Patients With Pulmonary Sarcoidosis

This report aims to determine the benefits of long-term use of methotrexate as a steroid-sparing agent for a patient with pulmonary sarcoidosis who cannot tolerate the glycemic effects of steroids. A search for articles using the medical subject heading terms “methotrexate” and “sarcoidosis” on PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Baiyasi, Ahmad F, Bangash, Najeebullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473589/
https://www.ncbi.nlm.nih.gov/pubmed/34595077
http://dx.doi.org/10.7759/cureus.17509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473589/
https://www.ncbi.nlm.nih.gov/pubmed/34595077
http://dx.doi.org/10.7759/cureus.17509

Ejemplares similares